Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102399305_102400285 | Sp1 | 6348 | 0.098947 | 0.56 | 3.1e-06 | Click! |
chr15_102405830_102405986 | Sp1 | 235 | 0.856683 | 0.49 | 6.6e-05 | Click! |
chr15_102404812_102405775 | Sp1 | 850 | 0.416577 | 0.44 | 4.9e-04 | Click! |
chr15_102410531_102410714 | Sp1 | 3034 | 0.132074 | 0.39 | 2.3e-03 | Click! |
chr15_102413987_102414138 | Sp1 | 6474 | 0.100911 | 0.23 | 7.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_19082814_19086200 | 23.60 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr5_125056018_125058841 | 18.85 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr7_25686795_25687582 | 16.11 |
Tgfb1 |
transforming growth factor, beta 1 |
186 |
0.88 |
chr2_153528339_153529939 | 16.07 |
Nol4l |
nucleolar protein 4-like |
832 |
0.63 |
chr12_86891509_86893562 | 14.93 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
7737 |
0.19 |
chrX_77432774_77434116 | 14.33 |
Gm5937 |
predicted gene 5937 |
23141 |
0.22 |
chr3_89386729_89388779 | 14.22 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
83 |
0.91 |
chr4_154024404_154026596 | 14.19 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr5_64810297_64813272 | 13.86 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr14_55061871_55064122 | 13.61 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr19_5724785_5726881 | 13.50 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr9_21961394_21962913 | 13.34 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr5_121711876_121713175 | 13.31 |
Atxn2 |
ataxin 2 |
444 |
0.71 |
chr11_75461625_75462791 | 12.83 |
Tlcd2 |
TLC domain containing 2 |
493 |
0.39 |
chr7_25249035_25250700 | 12.79 |
Erf |
Ets2 repressor factor |
863 |
0.36 |
chr9_89879614_89881129 | 12.56 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
29537 |
0.16 |
chr8_84703616_84705950 | 12.31 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr8_121082801_121085531 | 12.29 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr2_76648014_76648425 | 12.19 |
Prkra |
protein kinase, interferon inducible double stranded RNA dependent activator |
204 |
0.56 |
chr8_70493071_70496051 | 12.00 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr7_127026886_127027456 | 11.91 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
134 |
0.83 |
chr19_46623097_46624579 | 11.55 |
Wbp1l |
WW domain binding protein 1 like |
437 |
0.77 |
chr15_76521966_76524145 | 11.35 |
Scrt1 |
scratch family zinc finger 1 |
556 |
0.5 |
chr8_94976904_94978618 | 10.98 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
652 |
0.59 |
chr6_125088526_125090642 | 10.76 |
2010008C14Rik |
RIKEN cDNA 2010008C14 gene |
6147 |
0.07 |
chr7_142658126_142659753 | 10.62 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr11_116615789_116616584 | 10.59 |
Rhbdf2 |
rhomboid 5 homolog 2 |
8014 |
0.1 |
chr7_16844794_16846016 | 10.44 |
Prkd2 |
protein kinase D2 |
172 |
0.9 |
chr19_29805055_29806432 | 10.43 |
9930021J03Rik |
RIKEN cDNA 9930021J03 gene |
236 |
0.85 |
chr11_97434598_97436859 | 10.36 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr7_17055956_17057150 | 10.32 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
126 |
0.92 |
chr15_82379480_82380754 | 10.23 |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
126 |
0.88 |
chr10_81426043_81427197 | 10.16 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr10_127188246_127189758 | 10.09 |
Arhgef25 |
Rho guanine nucleotide exchange factor (GEF) 25 |
230 |
0.83 |
chr15_76197527_76199931 | 10.04 |
Plec |
plectin |
520 |
0.59 |
chr13_119961525_119962443 | 9.98 |
Gm20784 |
predicted gene, 20784 |
260 |
0.85 |
chr8_84200619_84201949 | 9.84 |
Gm37352 |
predicted gene, 37352 |
415 |
0.58 |
chr11_60175569_60177218 | 9.84 |
Rai1 |
retinoic acid induced 1 |
514 |
0.7 |
chr4_140701540_140702640 | 9.80 |
Rcc2 |
regulator of chromosome condensation 2 |
617 |
0.61 |
chr11_75655609_75656868 | 9.76 |
Myo1c |
myosin IC |
40 |
0.96 |
chr7_25626920_25628374 | 9.73 |
B3gnt8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
5 |
0.94 |
chr11_75165245_75169157 | 9.64 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr3_89391665_89393338 | 9.46 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
432 |
0.43 |
chr5_24426725_24429282 | 9.44 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
205 |
0.83 |
chr17_45736053_45737200 | 9.42 |
F630040K05Rik |
RIKEN cDNA F630040K05 gene |
2120 |
0.22 |
chr4_130173825_130175545 | 9.40 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr12_111442182_111444685 | 9.38 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr11_102217551_102219283 | 9.29 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr12_118300531_118301416 | 9.23 |
Sp4 |
trans-acting transcription factor 4 |
395 |
0.9 |
chr8_94984127_94985009 | 9.17 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
98 |
0.95 |
chr19_53140494_53142630 | 9.15 |
Add3 |
adducin 3 (gamma) |
12 |
0.97 |
chr10_127643084_127644231 | 9.14 |
Stat6 |
signal transducer and activator of transcription 6 |
655 |
0.49 |
chr18_37997868_37999258 | 9.09 |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
170 |
0.9 |
chr10_69910046_69911074 | 9.06 |
Ank3 |
ankyrin 3, epithelial |
4305 |
0.35 |
chr1_133800027_133801076 | 9.03 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
485 |
0.75 |
chr12_105981623_105981921 | 9.03 |
Vrk1 |
vaccinia related kinase 1 |
28456 |
0.18 |
chr6_38874889_38876891 | 8.94 |
Hipk2 |
homeodomain interacting protein kinase 2 |
33 |
0.9 |
chr4_134766990_134768275 | 8.88 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
392 |
0.86 |
chr5_137485098_137486372 | 8.87 |
Epo |
erythropoietin |
81 |
0.93 |
chr5_64159427_64160996 | 8.83 |
Tbc1d1 |
TBC1 domain family, member 1 |
0 |
0.97 |
chr7_19815910_19817895 | 8.81 |
Gm16174 |
predicted gene 16174 |
349 |
0.63 |
chr11_102308792_102311562 | 8.78 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr8_84706606_84708426 | 8.71 |
Nfix |
nuclear factor I/X |
200 |
0.88 |
chr17_27556596_27558077 | 8.67 |
Hmga1 |
high mobility group AT-hook 1 |
641 |
0.37 |
chr4_43522717_43524714 | 8.64 |
Tpm2 |
tropomyosin 2, beta |
50 |
0.93 |
chr7_100492685_100494805 | 8.56 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chrX_95967402_95968736 | 8.54 |
Las1l |
LAS1-like (S. cerevisiae) |
11107 |
0.24 |
chr3_84269309_84270900 | 8.49 |
Trim2 |
tripartite motif-containing 2 |
687 |
0.77 |
chr18_11051784_11053949 | 8.49 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr5_124094995_124096382 | 8.46 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
98 |
0.94 |
chr11_102296460_102297137 | 8.42 |
Atxn7l3 |
ataxin 7-like 3 |
167 |
0.9 |
chr14_100284227_100286288 | 8.37 |
Klf12 |
Kruppel-like factor 12 |
578 |
0.59 |
chr19_5662426_5664007 | 8.30 |
Sipa1 |
signal-induced proliferation associated gene 1 |
404 |
0.63 |
chr9_94538014_94538635 | 8.24 |
Dipk2a |
divergent protein kinase domain 2A |
243 |
0.94 |
chr10_127511678_127514192 | 8.17 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
2032 |
0.18 |
chr9_48648789_48650102 | 8.12 |
Nnmt |
nicotinamide N-methyltransferase |
44292 |
0.16 |
chr7_52005277_52006713 | 8.07 |
Svip |
small VCP/p97-interacting protein |
23 |
0.97 |
chr7_4776590_4778185 | 8.01 |
Il11 |
interleukin 11 |
754 |
0.38 |
chr11_98750268_98751902 | 7.99 |
Thra |
thyroid hormone receptor alpha |
2501 |
0.15 |
chr7_4751858_4753020 | 7.99 |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
89 |
0.92 |
chr7_101377838_101379825 | 7.95 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr1_64736856_64737984 | 7.93 |
Fzd5 |
frizzled class receptor 5 |
329 |
0.8 |
chr6_127151640_127154010 | 7.93 |
Ccnd2 |
cyclin D2 |
632 |
0.57 |
chr13_37826269_37827832 | 7.91 |
Rreb1 |
ras responsive element binding protein 1 |
118 |
0.96 |
chr1_181210767_181211914 | 7.89 |
Wdr26 |
WD repeat domain 26 |
86 |
0.96 |
chr10_80322682_80324056 | 7.89 |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
242 |
0.78 |
chr1_136173661_136174686 | 7.83 |
Kif21b |
kinesin family member 21B |
4859 |
0.13 |
chr4_151994846_151996125 | 7.80 |
Phf13 |
PHD finger protein 13 |
773 |
0.47 |
chr8_84741754_84745977 | 7.80 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
20858 |
0.09 |
chr1_75217955_75219308 | 7.78 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chr14_66279066_66281333 | 7.76 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr2_153560482_153561898 | 7.76 |
Nol4l |
nucleolar protein 4-like |
31219 |
0.15 |
chr9_21963175_21963912 | 7.75 |
Epor |
erythropoietin receptor |
37 |
0.94 |
chr11_103102696_103105788 | 7.75 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr7_144737389_144738828 | 7.71 |
Ano1 |
anoctamin 1, calcium activated chloride channel |
435 |
0.76 |
chr11_98953402_98955501 | 7.71 |
Rara |
retinoic acid receptor, alpha |
5961 |
0.11 |
chr11_22000607_22002265 | 7.70 |
Otx1 |
orthodenticle homeobox 1 |
179 |
0.96 |
chr17_45599296_45600146 | 7.68 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
115 |
0.92 |
chr17_47832362_47834525 | 7.65 |
Mdfi |
MyoD family inhibitor |
152 |
0.93 |
chr12_105008802_105010413 | 7.64 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
202 |
0.89 |
chr15_78926966_78928482 | 7.63 |
Lgals1 |
lectin, galactose binding, soluble 1 |
998 |
0.29 |
chr4_155562851_155563552 | 7.57 |
Nadk |
NAD kinase |
499 |
0.67 |
chr11_95833615_95836077 | 7.55 |
Abi3 |
ABI gene family, member 3 |
1044 |
0.33 |
chr15_84231290_84232731 | 7.52 |
Parvb |
parvin, beta |
33 |
0.97 |
chr8_70609276_70610571 | 7.49 |
Gm45546 |
predicted gene 45546 |
502 |
0.53 |
chrX_8271051_8272966 | 7.48 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr14_33362281_33363618 | 7.46 |
Arhgap22 |
Rho GTPase activating protein 22 |
573 |
0.71 |
chr17_25221667_25222954 | 7.45 |
Unkl |
unkempt family like zinc finger |
229 |
0.84 |
chr11_101260098_101261392 | 7.44 |
Wnk4 |
WNK lysine deficient protein kinase 4 |
90 |
0.91 |
chr15_76697284_76698616 | 7.44 |
Gpt |
glutamic pyruvic transaminase, soluble |
112 |
0.9 |
chr19_46304366_46306224 | 7.42 |
4833438C02Rik |
RIKEN cDNA 4833438C02 gene |
310 |
0.52 |
chrX_73909796_73911465 | 7.41 |
Arhgap4 |
Rho GTPase activating protein 4 |
599 |
0.57 |
chr10_42275609_42276721 | 7.40 |
Foxo3 |
forkhead box O3 |
531 |
0.84 |
chr16_21246022_21247222 | 7.39 |
Gm49750 |
predicted gene, 49750 |
8127 |
0.16 |
chr19_7164978_7166369 | 7.39 |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
34791 |
0.1 |
chr11_77606636_77607398 | 7.37 |
Taok1 |
TAO kinase 1 |
798 |
0.54 |
chr14_30625131_30626530 | 7.33 |
Prkcd |
protein kinase C, delta |
342 |
0.84 |
chr8_120487235_120488523 | 7.33 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
568 |
0.7 |
chr9_44486015_44488913 | 7.31 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr2_103958009_103958847 | 7.30 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr11_98446534_98448432 | 7.28 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr15_76194294_76195998 | 7.26 |
Plec |
plectin |
564 |
0.56 |
chr11_50127700_50128138 | 7.25 |
Gm12194 |
predicted gene 12194 |
1 |
0.96 |
chr9_22131114_22132438 | 7.24 |
Acp5 |
acid phosphatase 5, tartrate resistant |
39 |
0.93 |
chr13_29983771_29984979 | 7.21 |
E2f3 |
E2F transcription factor 3 |
16 |
0.98 |
chr14_20793089_20794019 | 7.20 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
412 |
0.6 |
chr4_141617213_141618510 | 7.17 |
Tmem82 |
transmembrane protein 82 |
120 |
0.93 |
chr17_33916115_33916647 | 7.16 |
Tapbp |
TAP binding protein |
195 |
0.45 |
chr8_23037877_23038537 | 7.15 |
Ank1 |
ankyrin 1, erythroid |
2976 |
0.25 |
chr2_91949326_91950727 | 7.14 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr13_45507294_45508710 | 7.13 |
Gmpr |
guanosine monophosphate reductase |
558 |
0.8 |
chr4_41135621_41136793 | 7.13 |
Ube2r2 |
ubiquitin-conjugating enzyme E2R 2 |
464 |
0.67 |
chr11_97439854_97442222 | 7.11 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr14_56886632_56887795 | 7.10 |
Zmym2 |
zinc finger, MYM-type 2 |
560 |
0.67 |
chr13_42051086_42051757 | 7.10 |
Hivep1 |
human immunodeficiency virus type I enhancer binding protein 1 |
600 |
0.73 |
chr1_75445319_75447338 | 7.08 |
Gmppa |
GDP-mannose pyrophosphorylase A |
4104 |
0.1 |
chr1_7398025_7398648 | 7.08 |
Gm26901 |
predicted gene, 26901 |
467 |
0.83 |
chr5_137746024_137747436 | 7.07 |
Tsc22d4 |
TSC22 domain family, member 4 |
734 |
0.45 |
chr8_23035959_23037041 | 7.06 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chrX_51204583_51205700 | 7.06 |
Mbnl3 |
muscleblind like splicing factor 3 |
691 |
0.63 |
chr2_156840101_156841614 | 7.06 |
Tgif2 |
TGFB-induced factor homeobox 2 |
165 |
0.85 |
chr13_38151091_38152938 | 7.04 |
Gm10129 |
predicted gene 10129 |
222 |
0.82 |
chr8_84701273_84703379 | 7.03 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr4_132074072_132075583 | 7.02 |
Gm10300 |
predicted gene 10300 |
130 |
0.8 |
chr8_71558187_71559532 | 7.02 |
Tmem221 |
transmembrane protein 221 |
12 |
0.94 |
chr17_29436785_29437867 | 7.02 |
Gm36486 |
predicted gene, 36486 |
122 |
0.94 |
chr4_106804374_106805428 | 7.01 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr11_77800451_77802048 | 7.01 |
Myo18a |
myosin XVIIIA |
49 |
0.97 |
chr19_6856906_6858230 | 7.01 |
Ccdc88b |
coiled-coil domain containing 88B |
643 |
0.54 |
chr15_99717549_99718677 | 7.00 |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
534 |
0.53 |
chr9_63756717_63758746 | 6.97 |
Smad3 |
SMAD family member 3 |
263 |
0.93 |
chrX_12087097_12088660 | 6.90 |
Bcor |
BCL6 interacting corepressor |
7325 |
0.28 |
chr2_48949582_48950662 | 6.84 |
Mbd5 |
methyl-CpG binding domain protein 5 |
21 |
0.56 |
chr14_61681602_61682334 | 6.84 |
Dleu2 |
deleted in lymphocytic leukemia, 2 |
334 |
0.54 |
chr7_5015147_5016025 | 6.83 |
Gm44973 |
predicted gene 44973 |
90 |
0.5 |
chr7_142474634_142476734 | 6.83 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr7_141338447_141340687 | 6.80 |
Eps8l2 |
EPS8-like 2 |
561 |
0.53 |
chr11_89298118_89300658 | 6.80 |
Nog |
noggin |
2944 |
0.27 |
chr19_5071378_5072755 | 6.79 |
Tmem151a |
transmembrane protein 151A |
66 |
0.61 |
chr4_53439742_53441333 | 6.74 |
Slc44a1 |
solute carrier family 44, member 1 |
124 |
0.97 |
chrX_151800545_151801407 | 6.72 |
Huwe1 |
HECT, UBA and WWE domain containing 1 |
93 |
0.96 |
chr10_79779842_79780833 | 6.72 |
Fstl3 |
follistatin-like 3 |
244 |
0.79 |
chr5_113162796_113163638 | 6.72 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
134 |
0.93 |
chr17_34893988_34894648 | 6.72 |
Zbtb12 |
zinc finger and BTB domain containing 12 |
241 |
0.72 |
chr10_80341789_80343949 | 6.71 |
Adamtsl5 |
ADAMTS-like 5 |
2369 |
0.1 |
chr17_57279123_57280459 | 6.71 |
Vav1 |
vav 1 oncogene |
664 |
0.59 |
chrX_12005788_12007643 | 6.70 |
Gm14512 |
predicted gene 14512 |
22247 |
0.22 |
chr19_6400799_6402159 | 6.70 |
Rasgrp2 |
RAS, guanyl releasing protein 2 |
216 |
0.85 |
chr8_94986231_94987228 | 6.69 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1161 |
0.36 |
chr4_149426748_149426912 | 6.68 |
Ube4b |
ubiquitination factor E4B |
81 |
0.95 |
chr17_34204808_34205708 | 6.67 |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
158 |
0.51 |
chr8_84722866_84724458 | 6.66 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr4_132973841_132975368 | 6.64 |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
502 |
0.76 |
chr2_119299920_119301063 | 6.64 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
11704 |
0.1 |
chr8_47989372_47991421 | 6.62 |
Wwc2 |
WW, C2 and coiled-coil domain containing 2 |
155 |
0.96 |
chr2_181241290_181242534 | 6.60 |
Helz2 |
helicase with zinc finger 2, transcriptional coactivator |
51 |
0.95 |
chr11_117888569_117891164 | 6.60 |
Tha1 |
threonine aldolase 1 |
16385 |
0.1 |
chr5_92128804_92129324 | 6.59 |
Uso1 |
USO1 vesicle docking factor |
8874 |
0.12 |
chr12_36042503_36042830 | 6.58 |
Tspan13 |
tetraspanin 13 |
166 |
0.95 |
chr7_97453001_97454277 | 6.58 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
417 |
0.79 |
chr12_76709422_76710754 | 6.57 |
Sptb |
spectrin beta, erythrocytic |
65 |
0.98 |
chr13_55210348_55211522 | 6.57 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
200 |
0.92 |
chr2_85060620_85061523 | 6.57 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
107 |
0.95 |
chr10_80584595_80587584 | 6.56 |
Abhd17a |
abhydrolase domain containing 17A |
535 |
0.53 |
chr11_98741842_98743057 | 6.53 |
Thra |
thyroid hormone receptor alpha |
291 |
0.81 |
chr11_90390569_90391222 | 6.51 |
Hlf |
hepatic leukemia factor |
0 |
0.99 |
chr6_125312691_125314238 | 6.49 |
Ltbr |
lymphotoxin B receptor |
199 |
0.88 |
chr5_134228074_134229115 | 6.47 |
Ncf1 |
neutrophil cytosolic factor 1 |
195 |
0.91 |
chr5_123131617_123134965 | 6.47 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr3_84814694_84815805 | 6.47 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
19 |
0.99 |
chr5_115433807_115437237 | 6.47 |
Msi1 |
musashi RNA-binding protein 1 |
24 |
0.93 |
chr5_137287809_137288794 | 6.46 |
Ache |
acetylcholinesterase |
16 |
0.82 |
chr17_12898079_12898969 | 6.45 |
Gm49926 |
predicted gene, 49926 |
987 |
0.29 |
chr7_25282462_25283397 | 6.45 |
Cic |
capicua transcriptional repressor |
119 |
0.92 |
chr10_42949531_42950836 | 6.43 |
Scml4 |
Scm polycomb group protein like 4 |
10302 |
0.19 |
chr4_109475656_109476957 | 6.42 |
Rnf11 |
ring finger protein 11 |
369 |
0.86 |
chrX_12151122_12152833 | 6.40 |
Bcor |
BCL6 interacting corepressor |
8369 |
0.25 |
chr1_172501767_172503923 | 6.40 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr4_124708520_124709496 | 6.39 |
Sf3a3 |
splicing factor 3a, subunit 3 |
5768 |
0.09 |
chr1_177257336_177258202 | 6.36 |
Akt3 |
thymoma viral proto-oncogene 3 |
177 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 24.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
6.9 | 20.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.9 | 17.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
5.5 | 16.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.4 | 16.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
5.3 | 21.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
5.0 | 9.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.9 | 24.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
4.7 | 14.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
4.6 | 13.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.3 | 17.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.2 | 16.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
4.2 | 4.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
4.2 | 12.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
4.1 | 16.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
3.9 | 11.8 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
3.9 | 11.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
3.6 | 14.5 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
3.6 | 3.6 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
3.6 | 10.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
3.5 | 10.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
3.5 | 10.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.4 | 10.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.3 | 13.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
3.3 | 29.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
3.3 | 23.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.3 | 13.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.2 | 12.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
3.2 | 9.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
3.2 | 9.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
3.1 | 9.4 | GO:0008050 | female courtship behavior(GO:0008050) |
3.1 | 9.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
3.0 | 15.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.0 | 6.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.0 | 8.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.9 | 2.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.9 | 8.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.9 | 14.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
2.9 | 11.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
2.9 | 11.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.8 | 2.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
2.8 | 8.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.8 | 27.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.8 | 8.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.8 | 24.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.7 | 16.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.7 | 8.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.7 | 10.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.7 | 5.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.6 | 7.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.6 | 2.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.6 | 7.7 | GO:0002432 | granuloma formation(GO:0002432) |
2.5 | 7.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
2.5 | 7.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.5 | 5.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.5 | 9.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.4 | 7.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.4 | 7.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.4 | 12.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.4 | 7.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.4 | 4.8 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
2.4 | 14.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
2.3 | 35.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.3 | 7.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.3 | 7.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.3 | 23.2 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
2.3 | 6.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.3 | 4.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.3 | 2.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.3 | 4.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.3 | 6.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.3 | 4.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.3 | 9.1 | GO:0007296 | vitellogenesis(GO:0007296) |
2.3 | 4.5 | GO:0015793 | glycerol transport(GO:0015793) |
2.2 | 8.8 | GO:0006848 | pyruvate transport(GO:0006848) |
2.2 | 15.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.2 | 4.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.2 | 6.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
2.2 | 4.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
2.2 | 8.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.2 | 8.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.1 | 17.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.1 | 6.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.1 | 8.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.1 | 6.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.1 | 8.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
2.1 | 2.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
2.1 | 4.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.1 | 6.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.0 | 8.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.0 | 6.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.0 | 10.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
2.0 | 12.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
2.0 | 6.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.0 | 4.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.0 | 9.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.0 | 13.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.0 | 5.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.0 | 7.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.0 | 5.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.0 | 5.9 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.0 | 5.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.0 | 5.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.9 | 9.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.9 | 5.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.9 | 1.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
1.9 | 15.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.9 | 5.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.9 | 3.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.9 | 13.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.9 | 11.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.9 | 5.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.9 | 11.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.8 | 5.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.8 | 1.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.8 | 9.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.8 | 5.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.8 | 7.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.8 | 12.8 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
1.8 | 5.5 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 5.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.8 | 5.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.8 | 9.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.8 | 16.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.8 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.8 | 7.1 | GO:0044838 | cell quiescence(GO:0044838) |
1.8 | 3.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.8 | 5.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.8 | 5.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.7 | 5.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 3.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.7 | 1.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.7 | 5.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.7 | 5.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.7 | 8.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.7 | 12.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
1.7 | 1.7 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
1.7 | 6.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.7 | 11.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.7 | 3.4 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.7 | 15.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.7 | 5.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.7 | 5.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 6.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.7 | 8.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.7 | 5.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.7 | 6.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.6 | 9.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.6 | 4.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.6 | 1.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.6 | 1.6 | GO:0072275 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.6 | 19.6 | GO:0051601 | exocyst localization(GO:0051601) |
1.6 | 14.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.6 | 17.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.6 | 4.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.6 | 6.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.6 | 8.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.6 | 6.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.6 | 6.4 | GO:0018214 | protein carboxylation(GO:0018214) |
1.6 | 38.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.6 | 9.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.6 | 4.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.6 | 4.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.6 | 4.7 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.6 | 4.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.6 | 9.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.6 | 1.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.6 | 3.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.6 | 14.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 9.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.5 | 10.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.5 | 21.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.5 | 7.7 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.5 | 15.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.5 | 12.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.5 | 6.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.5 | 6.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
1.5 | 3.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.5 | 4.6 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.5 | 4.6 | GO:0007525 | somatic muscle development(GO:0007525) |
1.5 | 1.5 | GO:0051182 | coenzyme transport(GO:0051182) |
1.5 | 4.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.5 | 3.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.5 | 4.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.5 | 6.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.5 | 21.1 | GO:0015858 | nucleoside transport(GO:0015858) |
1.5 | 6.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.5 | 1.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.5 | 6.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.5 | 3.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.5 | 4.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.5 | 3.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.5 | 1.5 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.5 | 3.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 3.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.5 | 7.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.5 | 14.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.5 | 3.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.5 | 2.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.5 | 8.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
1.5 | 1.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.5 | 14.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.5 | 4.4 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.5 | 2.9 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
1.4 | 5.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.4 | 7.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.4 | 4.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.4 | 4.3 | GO:0000087 | mitotic M phase(GO:0000087) |
1.4 | 4.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.4 | 17.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.4 | 4.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.4 | 7.1 | GO:0019695 | choline metabolic process(GO:0019695) |
1.4 | 2.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 1.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.4 | 7.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.4 | 4.3 | GO:0048143 | astrocyte activation(GO:0048143) |
1.4 | 5.7 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.4 | 15.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.4 | 4.3 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.4 | 2.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.4 | 5.6 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.4 | 7.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
1.4 | 4.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.4 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.4 | 2.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.4 | 4.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 6.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.4 | 5.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.4 | 4.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.4 | 4.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.4 | 6.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.4 | 2.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.4 | 2.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.4 | 4.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.4 | 10.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.3 | 8.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 4.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 2.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.3 | 4.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.3 | 4.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.3 | 1.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.3 | 6.6 | GO:0034405 | response to fluid shear stress(GO:0034405) |
1.3 | 6.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.3 | 1.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
1.3 | 5.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 6.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.3 | 2.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.3 | 1.3 | GO:0015791 | polyol transport(GO:0015791) |
1.3 | 1.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.3 | 3.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.3 | 24.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.3 | 1.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
1.3 | 19.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.3 | 6.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.3 | 2.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.3 | 3.9 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.3 | 7.8 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.3 | 1.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.3 | 10.3 | GO:0034063 | stress granule assembly(GO:0034063) |
1.3 | 15.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.3 | 1.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.3 | 7.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.3 | 12.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.3 | 12.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.3 | 1.3 | GO:0051593 | response to folic acid(GO:0051593) |
1.3 | 15.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.3 | 10.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.3 | 7.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.3 | 1.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.3 | 3.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 17.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.3 | 5.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.3 | 10.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 5.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.3 | 8.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.3 | 5.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.3 | 10.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.3 | 3.8 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
1.3 | 1.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.2 | 13.7 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.2 | 6.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.2 | 2.5 | GO:0061010 | gall bladder development(GO:0061010) |
1.2 | 1.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.2 | 1.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.2 | 2.5 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
1.2 | 8.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.2 | 7.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.2 | 9.8 | GO:0072537 | fibroblast activation(GO:0072537) |
1.2 | 13.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.2 | 2.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.2 | 8.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.2 | 2.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.2 | 1.2 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
1.2 | 4.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.2 | 3.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 9.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.2 | 2.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 6.0 | GO:0006116 | NADH oxidation(GO:0006116) |
1.2 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.2 | 3.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.2 | 3.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.2 | 3.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.2 | 3.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.2 | 1.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.2 | 1.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
1.2 | 2.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.2 | 1.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
1.2 | 4.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.2 | 4.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 5.8 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.2 | 3.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.2 | 2.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.2 | 1.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.2 | 4.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.2 | 2.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.2 | 2.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.2 | 5.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.2 | 3.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.2 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.2 | 2.3 | GO:0002339 | B cell selection(GO:0002339) |
1.1 | 1.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.1 | 41.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.1 | 3.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.1 | 3.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 1.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.1 | 3.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.1 | 18.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.1 | 4.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.1 | 2.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.1 | 7.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.1 | 2.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.1 | 2.3 | GO:0048382 | mesendoderm development(GO:0048382) |
1.1 | 3.4 | GO:1903798 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
1.1 | 12.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.1 | 3.4 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.1 | 4.5 | GO:0048102 | autophagic cell death(GO:0048102) |
1.1 | 3.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.1 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 4.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.1 | 1.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
1.1 | 4.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.1 | 7.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.1 | 2.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
1.1 | 4.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
1.1 | 4.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.1 | 1.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 2.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.1 | 1.1 | GO:0045472 | response to ether(GO:0045472) |
1.1 | 1.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.1 | 4.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.1 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.1 | 16.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.1 | 1.1 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.1 | 4.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 12.0 | GO:0042026 | protein refolding(GO:0042026) |
1.1 | 10.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.1 | 4.3 | GO:0008228 | opsonization(GO:0008228) |
1.1 | 2.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 8.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.1 | 1.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.1 | 1.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
1.1 | 8.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 8.6 | GO:0031579 | membrane raft organization(GO:0031579) |
1.1 | 5.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.1 | 3.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 2.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.1 | 10.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.1 | 3.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.1 | 9.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.1 | 10.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.1 | 6.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 2.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.1 | 1.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.1 | 1.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 7.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.1 | 5.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.1 | 3.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
1.1 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.1 | 3.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.1 | 3.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.1 | 1.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.0 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
1.0 | 2.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.0 | 4.2 | GO:0021764 | amygdala development(GO:0021764) |
1.0 | 5.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.0 | 2.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.0 | 4.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.0 | 1.0 | GO:0032310 | prostaglandin secretion(GO:0032310) |
1.0 | 11.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 1.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.0 | 3.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.0 | 9.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.0 | 4.1 | GO:0007097 | nuclear migration(GO:0007097) |
1.0 | 3.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.0 | 1.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.0 | 3.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.0 | 2.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
1.0 | 3.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.0 | 3.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.0 | 1.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 2.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 2.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.0 | 4.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
1.0 | 5.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.0 | 5.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 5.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.0 | 3.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 3.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.0 | 3.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 5.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.0 | 5.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 1.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.0 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.0 | 2.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.0 | 2.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.0 | 2.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
1.0 | 4.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.0 | 3.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.0 | 6.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.0 | 5.9 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
1.0 | 1.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
1.0 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.0 | 3.0 | GO:0070293 | renal absorption(GO:0070293) |
1.0 | 2.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.0 | 3.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.0 | 2.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 2.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.0 | 4.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.0 | 2.9 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.0 | 5.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.0 | 14.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.0 | 1.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.0 | 4.9 | GO:0010226 | response to lithium ion(GO:0010226) |
1.0 | 2.9 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.0 | 10.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 7.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.0 | 3.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.0 | 2.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.0 | 3.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 10.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.0 | 4.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 3.8 | GO:0048478 | replication fork protection(GO:0048478) |
1.0 | 4.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 6.7 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
1.0 | 9.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.0 | 2.9 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.0 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.0 | 5.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.0 | 2.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.0 | 3.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.9 | 0.9 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.9 | 0.9 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.9 | 2.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 9.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.9 | 3.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 12.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.9 | 2.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.9 | 29.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.9 | 2.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 1.9 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.9 | 3.8 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 1.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 7.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 2.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.9 | 4.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 2.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.9 | 2.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.9 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.9 | 1.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.9 | 0.9 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.9 | 4.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.9 | 3.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.9 | 4.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.9 | 5.5 | GO:0060613 | fat pad development(GO:0060613) |
0.9 | 2.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.9 | 1.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 2.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.9 | 12.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.9 | 9.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.9 | 4.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.9 | 3.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 2.7 | GO:0009838 | abscission(GO:0009838) |
0.9 | 2.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 2.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.9 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.9 | 2.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.9 | 2.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.9 | 1.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.9 | 10.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.9 | 2.7 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.9 | 10.9 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.9 | 2.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.9 | 2.7 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.9 | 2.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.9 | 3.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.9 | 2.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.9 | 4.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.9 | 1.8 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.9 | 0.9 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.9 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.9 | 2.7 | GO:0097286 | iron ion import(GO:0097286) |
0.9 | 6.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.9 | 5.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.9 | 0.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.9 | 1.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.9 | 2.7 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.9 | 1.8 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.9 | 0.9 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.9 | 3.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.9 | 0.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.9 | 1.7 | GO:0019042 | viral latency(GO:0019042) |
0.9 | 11.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.9 | 3.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 0.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.9 | 1.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.9 | 7.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.9 | 1.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.9 | 6.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.9 | 3.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.9 | 2.6 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 3.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.9 | 6.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.9 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.9 | 1.7 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.9 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 6.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.8 | 2.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 1.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.8 | 3.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.8 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.8 | 2.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.8 | 5.1 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.8 | 5.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.8 | 0.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.8 | 3.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 3.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 3.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.8 | 4.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.8 | 2.5 | GO:0051029 | rRNA transport(GO:0051029) |
0.8 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.8 | 2.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.8 | 2.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.8 | 5.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.8 | 2.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.8 | 4.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.8 | 7.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.8 | 0.8 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.8 | 5.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.8 | 2.5 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.8 | 2.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.8 | 14.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.8 | 2.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.8 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.8 | 4.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.8 | 3.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 4.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.8 | 1.6 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.8 | 2.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.8 | 0.8 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.8 | 2.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.8 | 2.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 3.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.8 | 2.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 4.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.8 | 12.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.8 | 2.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.8 | 1.6 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.8 | 1.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.8 | 2.4 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.8 | 1.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.8 | 0.8 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.8 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 4.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.8 | 9.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.8 | 0.8 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.8 | 2.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 2.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.8 | 4.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.8 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 2.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.8 | 4.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 1.6 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.8 | 2.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.8 | 5.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 1.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.8 | 14.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.8 | 3.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.8 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.8 | 3.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 1.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 3.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.8 | 2.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 1.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.8 | 0.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.8 | 1.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 1.6 | GO:0015677 | copper ion import(GO:0015677) |
0.8 | 1.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.8 | 1.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.8 | 3.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 4.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 1.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.8 | 2.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 0.8 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 2.3 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.8 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 0.8 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.8 | 0.8 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.8 | 2.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.8 | 10.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.8 | 0.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.8 | 4.6 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 4.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 3.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 4.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.8 | 7.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.8 | 2.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.8 | 5.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.8 | 4.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 3.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.8 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.8 | 2.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 2.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 1.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.8 | 6.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.7 | 2.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.7 | 9.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.7 | 1.5 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.7 | 8.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 18.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.7 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 4.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.7 | 3.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 0.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.7 | 1.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 0.7 | GO:0032661 | dendritic cell cytokine production(GO:0002371) regulation of interleukin-18 production(GO:0032661) |
0.7 | 4.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.7 | 1.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 2.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 2.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 1.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 2.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.7 | 2.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 2.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.7 | 3.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.7 | 0.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.7 | 2.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.2 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 5.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.7 | 3.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.7 | 3.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.7 | 27.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.7 | 6.5 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.7 | 5.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.7 | 2.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.7 | 16.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.7 | 1.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.7 | 2.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.7 | 2.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 0.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.7 | 4.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.7 | 4.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.7 | 5.7 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.7 | 2.1 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 10.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.7 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 3.5 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.7 | 6.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 1.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.7 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 4.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.7 | 5.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.7 | 2.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 5.6 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.7 | 2.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 2.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.7 | 1.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 2.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 6.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.7 | 1.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 1.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 2.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.7 | 2.8 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 1.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.7 | 2.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 2.8 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.7 | 0.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.7 | 7.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.7 | 7.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 1.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.7 | 2.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.7 | 1.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 0.7 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.7 | 1.4 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 2.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.7 | 23.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 0.7 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.7 | 2.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.7 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.7 | 4.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.7 | 2.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.7 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 6.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 22.4 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.7 | 1.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 0.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.7 | 4.1 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.7 | 1.4 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.7 | 1.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 6.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.7 | 5.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.7 | 1.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.7 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.7 | 4.7 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.7 | 4.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.7 | 2.0 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.7 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.7 | 2.7 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.7 | 6.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 2.0 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.7 | 8.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.7 | 1.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.7 | 2.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.7 | 5.3 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.7 | 1.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 1.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 0.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 1.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.7 | 2.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.7 | 3.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.7 | 1.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.7 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 2.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.6 | 37.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.6 | 5.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.6 | 5.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.6 | 6.4 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.6 | 1.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 10.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 3.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 1.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 1.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.6 | 11.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.6 | 1.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.6 | 1.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.6 | 0.6 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.6 | 3.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 0.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.6 | 13.2 | GO:0007569 | cell aging(GO:0007569) |
0.6 | 1.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 2.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.6 | 3.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 1.2 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.6 | 2.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.6 | 1.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 1.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 1.9 | GO:0042148 | strand invasion(GO:0042148) |
0.6 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 6.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 3.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 2.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.6 | 8.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.6 | 6.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.6 | 11.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 2.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.6 | 4.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 11.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.6 | 4.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 11.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.6 | 3.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 10.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.6 | 4.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 1.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.6 | 1.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 1.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 1.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 4.8 | GO:0035690 | cellular response to drug(GO:0035690) |
0.6 | 2.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.6 | 1.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 0.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.6 | 3.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 2.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 4.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.6 | 1.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 3.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 6.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.6 | 3.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 3.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 2.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 1.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 2.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.6 | 1.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.6 | 3.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.6 | 0.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 2.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 1.8 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.6 | 4.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.6 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 2.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 2.9 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.6 | 3.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.6 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 0.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.6 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 0.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.6 | 4.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 4.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 1.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 2.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 2.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 1.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.6 | 0.6 | GO:0044860 | protein transport into membrane raft(GO:0032596) protein localization to plasma membrane raft(GO:0044860) |
0.6 | 3.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 3.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 8.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.6 | 4.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 0.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 1.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 0.6 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.6 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 7.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.6 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.6 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 7.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 1.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 0.6 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.6 | 1.7 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.6 | 0.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.6 | 4.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.6 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 2.8 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.6 | 1.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.6 | 3.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.6 | 7.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.6 | 1.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.6 | 0.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.6 | 11.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.6 | 2.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 1.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 2.7 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.5 | 10.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 1.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.5 | 2.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 2.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 8.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 2.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.5 | 0.5 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.5 | 1.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 11.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.5 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 0.5 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.5 | 1.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 2.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.5 | 2.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 2.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 0.5 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 1.1 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.5 | 4.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.5 | 10.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 5.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 7.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.5 | 1.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.5 | 2.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 0.5 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.5 | 8.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.5 | 2.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.5 | 1.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 2.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.5 | 1.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 0.5 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.5 | 2.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 0.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.5 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 2.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 2.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 5.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.5 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.5 | 1.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.5 | 1.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 18.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.5 | 1.0 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.5 | 4.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 1.5 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 2.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 6.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 0.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.5 | 10.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 4.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.5 | 3.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 33.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.5 | 1.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.5 | 2.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 5.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.5 | 1.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.5 | 2.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.5 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.5 | 1.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.5 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.0 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
0.5 | 1.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.5 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 1.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.5 | 1.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.5 | 1.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.5 | 1.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 2.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.5 | 1.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.5 | 1.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.5 | 0.5 | GO:0048308 | organelle inheritance(GO:0048308) |
0.5 | 23.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 1.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 1.9 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.5 | 1.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.4 | GO:0033363 | secretory granule organization(GO:0033363) |
0.5 | 1.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.5 | 16.8 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.5 | 1.9 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.5 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 0.5 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.5 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 6.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 9.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.5 | 9.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.5 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.8 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 2.3 | GO:0046697 | decidualization(GO:0046697) |
0.5 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 3.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.5 | 0.9 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.5 | 12.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.5 | 0.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.5 | 4.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 1.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 2.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.5 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 0.9 | GO:0006476 | protein deacetylation(GO:0006476) |
0.5 | 4.1 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.5 | 3.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.5 | 4.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.5 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 7.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 5.8 | GO:0061515 | myeloid cell development(GO:0061515) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 0.9 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) |
0.4 | 1.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 0.9 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 4.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 1.8 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.4 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 3.1 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
0.4 | 2.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 0.9 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 16.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.4 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 0.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 2.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 6.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.4 | 1.7 | GO:0060770 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 1.7 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 1.7 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.4 | 0.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 4.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.4 | 8.6 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.4 | 0.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 7.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 0.9 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.4 | 2.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 0.9 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 1.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 22.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.4 | 1.7 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.4 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 3.0 | GO:0007602 | phototransduction(GO:0007602) |
0.4 | 2.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 2.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 7.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 38.3 | GO:0006260 | DNA replication(GO:0006260) |
0.4 | 2.1 | GO:0060896 | neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.4 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.4 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 0.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 2.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 2.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 2.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.4 | 2.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.4 | 0.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.4 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 0.4 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.4 | 3.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.4 | 5.6 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.4 | 3.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 2.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.4 | 3.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 0.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.9 | GO:0070265 | necrotic cell death(GO:0070265) |
0.4 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 1.6 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.8 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.4 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 10.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.4 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.4 | 2.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 1.5 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.4 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 15.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 1.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.4 | 2.3 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.4 | 1.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.4 | 0.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.8 | GO:0044241 | lipid digestion(GO:0044241) |
0.4 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 6.0 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.4 | 2.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.4 | 0.7 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 4.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 19.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.4 | 0.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 11.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.4 | 0.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 7.4 | GO:0045010 | actin nucleation(GO:0045010) |
0.4 | 0.4 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.4 | 0.7 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.4 | 4.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 0.4 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.4 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.4 | 3.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 0.7 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.4 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 3.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 14.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 4.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.4 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 5.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 2.9 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.4 | 1.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 5.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 3.5 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.4 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.4 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.4 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 6.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 0.4 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.4 | 0.7 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 1.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 4.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 4.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 1.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 1.0 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.3 | 9.3 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 10.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 2.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.3 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 2.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.4 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 4.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 2.0 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.3 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.3 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 2.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 3.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 1.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 1.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 6.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 3.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 2.2 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 1.9 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.3 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 1.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 1.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 1.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.3 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 2.2 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.3 | 1.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.3 | 0.6 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.3 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.6 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 1.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 0.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 2.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 5.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 3.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 3.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 1.5 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.3 | 3.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 1.4 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.3 | 0.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.3 | 2.3 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.3 | 0.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.3 | 0.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.3 | 0.6 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 3.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.6 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.3 | 0.3 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.3 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.3 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 1.4 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.3 | 2.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.3 | 2.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 6.2 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 2.0 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.3 | 1.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 1.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 7.3 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.3 | 2.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.3 | 1.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 6.7 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.3 | 1.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.3 | 8.8 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.3 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 0.5 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.3 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.8 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 2.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 2.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 2.7 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.3 | 1.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 2.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 12.1 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 0.8 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.3 | 0.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.3 | 7.0 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.3 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 0.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.8 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.3 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 1.3 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.3 | 1.5 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 2.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 2.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 5.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 11.3 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.2 | 6.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 1.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 4.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 1.2 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 1.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 1.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.9 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 20.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.2 | 0.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.2 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.2 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.2 | 2.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 3.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.4 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.2 | 2.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 3.1 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.2 | 6.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 2.6 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.2 | 4.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 26.5 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.2 | 1.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.2 | 0.8 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.2 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.2 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.2 | 0.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.7 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.2 | 1.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.6 | GO:2000269 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 1.0 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.2 | 1.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 2.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 1.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.2 | 0.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 1.0 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.2 | 0.8 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 2.8 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 3.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 2.3 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.2 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.2 | 0.2 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.2 | 2.1 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.7 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.2 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.2 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 3.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 2.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 2.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 0.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.5 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.2 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 1.5 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.7 | GO:0071514 | genetic imprinting(GO:0071514) |
0.2 | 0.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.5 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.2 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.2 | GO:0071634 | regulation of transforming growth factor beta production(GO:0071634) |
0.2 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 3.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 1.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.2 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.2 | 0.8 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.2 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 1.0 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 1.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 1.3 | GO:0046031 | ADP metabolic process(GO:0046031) |
0.1 | 0.1 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 1.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.9 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.3 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.4 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 3.2 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 1.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 1.8 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 1.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0034982 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.1 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.9 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 1.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 1.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 2.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.1 | 1.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 1.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 2.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.1 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.1 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.3 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 1.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.6 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.2 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 3.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.8 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.5 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.1 | GO:0046471 | cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.2 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) |
0.1 | 0.8 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 1.0 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 3.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.6 | GO:0002764 | immune response-regulating signaling pathway(GO:0002764) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 5.5 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
0.1 | 0.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.9 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.4 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.5 | GO:0055006 | cardiac cell development(GO:0055006) |
0.0 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.3 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 3.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 3.5 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.0 | 0.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 3.3 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.2 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.9 | GO:0007599 | hemostasis(GO:0007599) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 1.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.0 | 0.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 2.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.0 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.0 | 0.0 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.4 | 26.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.2 | 8.3 | GO:0005667 | transcription factor complex(GO:0005667) |
3.4 | 17.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.8 | 13.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.7 | 8.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.7 | 10.8 | GO:0005642 | annulate lamellae(GO:0005642) |
2.6 | 10.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.6 | 10.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.5 | 10.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
2.5 | 7.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
2.5 | 10.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.4 | 7.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.4 | 9.7 | GO:0072487 | MSL complex(GO:0072487) |
2.2 | 6.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.1 | 17.0 | GO:0001650 | fibrillar center(GO:0001650) |
2.1 | 16.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.1 | 8.2 | GO:0042825 | TAP complex(GO:0042825) |
2.0 | 24.3 | GO:0071564 | npBAF complex(GO:0071564) |
2.0 | 12.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.0 | 17.8 | GO:0000124 | SAGA complex(GO:0000124) |
2.0 | 15.8 | GO:0030056 | hemidesmosome(GO:0030056) |
1.9 | 7.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.9 | 7.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.8 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.8 | 7.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.8 | 5.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.8 | 9.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.7 | 5.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.7 | 5.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.7 | 1.7 | GO:0071437 | invadopodium(GO:0071437) |
1.7 | 6.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.7 | 16.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 24.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.5 | 6.1 | GO:0030478 | actin cap(GO:0030478) |
1.5 | 9.1 | GO:0001739 | sex chromatin(GO:0001739) |
1.5 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.5 | 31.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.5 | 5.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.5 | 14.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.5 | 17.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.4 | 1.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.4 | 4.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 7.1 | GO:0005638 | lamin filament(GO:0005638) |
1.4 | 4.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.4 | 5.6 | GO:0000805 | X chromosome(GO:0000805) |
1.4 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 8.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.3 | 4.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.3 | 3.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.3 | 5.2 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 11.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.3 | 5.1 | GO:0071203 | WASH complex(GO:0071203) |
1.3 | 3.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.3 | 2.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.2 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.2 | 2.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 3.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.2 | 11.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.2 | 8.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.2 | 37.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.2 | 19.2 | GO:0000145 | exocyst(GO:0000145) |
1.2 | 6.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 4.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 65.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 14.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.2 | 4.6 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.1 | 4.6 | GO:0030891 | VCB complex(GO:0030891) |
1.1 | 5.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 3.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 10.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.1 | 4.5 | GO:0070876 | SOSS complex(GO:0070876) |
1.1 | 5.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.1 | 5.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.1 | 3.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.1 | 5.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.1 | 6.6 | GO:0090543 | Flemming body(GO:0090543) |
1.1 | 3.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.1 | 6.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 3.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.1 | 3.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.1 | 7.5 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 11.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.1 | 13.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.1 | 5.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.1 | 2.1 | GO:0072687 | meiotic spindle(GO:0072687) |
1.1 | 10.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.1 | 2.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 1.0 | GO:0042581 | specific granule(GO:0042581) |
1.0 | 43.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.0 | 1.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.0 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 7.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.0 | 5.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.0 | 8.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.0 | 8.2 | GO:0001939 | female pronucleus(GO:0001939) |
1.0 | 7.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 9.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.0 | 15.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.0 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.0 | 3.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 12.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 13.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.0 | 2.9 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 45.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.0 | 2.9 | GO:0071942 | XPC complex(GO:0071942) |
1.0 | 2.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.0 | 3.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 5.7 | GO:1990462 | omegasome(GO:1990462) |
1.0 | 3.8 | GO:0045298 | tubulin complex(GO:0045298) |
1.0 | 1.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 3.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.0 | 3.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 2.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 2.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.9 | 2.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.9 | 4.7 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 6.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 2.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.9 | 6.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 53.1 | GO:0016605 | PML body(GO:0016605) |
0.9 | 3.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 20.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.9 | 3.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.9 | 7.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.9 | 5.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 21.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 24.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.9 | 57.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.9 | 4.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.9 | 3.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.9 | 2.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 4.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 4.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 2.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.8 | 2.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.8 | 5.8 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 5.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.8 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 5.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.8 | 4.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 8.9 | GO:0038201 | TOR complex(GO:0038201) |
0.8 | 1.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.8 | 12.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 4.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 4.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 30.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.8 | 6.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 2.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 13.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.8 | 3.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 3.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.8 | 2.3 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 7.8 | GO:0032039 | integrator complex(GO:0032039) |
0.8 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 7.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 4.7 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 2.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 1.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.8 | 3.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.8 | 10.8 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.8 | 6.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 35.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 9.2 | GO:0005844 | polysome(GO:0005844) |
0.8 | 4.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 6.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 8.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 1.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 1.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 3.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 4.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.7 | 3.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 199.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.7 | 5.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 2.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 1.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 2.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 3.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 1.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.7 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 4.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 2.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 1.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.7 | 9.1 | GO:0043218 | compact myelin(GO:0043218) |
0.7 | 5.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.7 | 2.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 3.5 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 2.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 38.3 | GO:0005902 | microvillus(GO:0005902) |
0.7 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 7.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.7 | 22.1 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 13.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.7 | 30.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 4.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.7 | 5.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.7 | 4.6 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 2.0 | GO:0036396 | MIS complex(GO:0036396) |
0.7 | 2.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.7 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 8.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.6 | 139.1 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 1.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 7.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 28.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 24.4 | GO:0016459 | myosin complex(GO:0016459) |
0.6 | 2.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 4.4 | GO:0002102 | podosome(GO:0002102) |
0.6 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 6.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.6 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 4.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 9.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 4.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 1.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 3.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 27.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.6 | 1.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 3.6 | GO:0000801 | central element(GO:0000801) |
0.6 | 2.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 12.6 | GO:0036379 | myofilament(GO:0036379) |
0.6 | 64.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.6 | 2.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 3.0 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 4.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 7.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.6 | 2.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 39.9 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 3.5 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.6 | 5.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 2.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 5.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 8.0 | GO:0005605 | basal lamina(GO:0005605) |
0.6 | 2.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 8.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 1.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 57.5 | GO:0019867 | mitochondrial outer membrane(GO:0005741) outer membrane(GO:0019867) |
0.6 | 2.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 1.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.6 | 9.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 7.2 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 51.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 3.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 2.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.5 | 2.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 5.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.5 | 5.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 10.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 1.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 1.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 19.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 2.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 11.8 | GO:0005657 | replication fork(GO:0005657) |
0.5 | 1.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 8.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 7.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 20.4 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 38.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.5 | 11.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.5 | 585.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.5 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 2.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.5 | 4.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 4.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 2.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 1.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 4.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 2.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 1.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 29.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 3.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 1.4 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 22.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 2.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 13.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.5 | 23.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.5 | 5.0 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 4.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 19.9 | GO:0005938 | cell cortex(GO:0005938) |
0.4 | 2.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 9.6 | GO:0044452 | nucleolar part(GO:0044452) |
0.4 | 51.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 1.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 4.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 91.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.4 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 3.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 122.2 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 9.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 2.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 0.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 1.6 | GO:0002177 | manchette(GO:0002177) |
0.4 | 1.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 1.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.4 | 3.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 7.3 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 12.5 | GO:0030496 | midbody(GO:0030496) |
0.4 | 1.4 | GO:0036452 | ESCRT complex(GO:0036452) |
0.4 | 8.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 59.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 2.8 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 2.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 3.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 42.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 3.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.3 | 16.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 5.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 3.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.2 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.3 | 4.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.3 | 19.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 2.2 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 6.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 19.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 0.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.3 | 1.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 348.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 1.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 7.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 121.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 6.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.6 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 15.5 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 4.3 | GO:0005814 | centriole(GO:0005814) |
0.2 | 8.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 11.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 1.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 5.1 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 89.0 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 2.1 | GO:1990234 | transferase complex(GO:1990234) |
0.2 | 1.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 16.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 2.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 19.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 68.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 4.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.0 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 74.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 21.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
4.4 | 4.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
4.0 | 12.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.9 | 11.6 | GO:0050692 | DBD domain binding(GO:0050692) |
3.4 | 13.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.2 | 9.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.1 | 12.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
3.1 | 9.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
3.0 | 9.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.0 | 9.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.0 | 5.9 | GO:0048030 | disaccharide binding(GO:0048030) |
2.9 | 11.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.9 | 8.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.8 | 8.4 | GO:1990188 | euchromatin binding(GO:1990188) |
2.8 | 22.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.7 | 8.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.7 | 8.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.6 | 7.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.6 | 12.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.5 | 30.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.5 | 7.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.5 | 9.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.4 | 19.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
2.4 | 7.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.3 | 20.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.3 | 13.8 | GO:0030274 | LIM domain binding(GO:0030274) |
2.3 | 6.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.2 | 9.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.2 | 6.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.2 | 4.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.2 | 15.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.2 | 13.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.2 | 6.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.2 | 13.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.2 | 6.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.1 | 8.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.1 | 6.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.1 | 14.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.1 | 10.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.1 | 10.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.1 | 6.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.0 | 20.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.0 | 12.1 | GO:0004064 | arylesterase activity(GO:0004064) |
2.0 | 5.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.9 | 21.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.9 | 5.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.9 | 5.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.9 | 3.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.9 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.9 | 9.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.8 | 20.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.8 | 1.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.8 | 7.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.8 | 10.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.8 | 10.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.8 | 5.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.8 | 5.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.7 | 6.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.7 | 5.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.7 | 6.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.7 | 10.0 | GO:0043426 | MRF binding(GO:0043426) |
1.7 | 5.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.7 | 13.3 | GO:0035197 | siRNA binding(GO:0035197) |
1.7 | 1.7 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.6 | 9.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.6 | 4.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.6 | 4.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.6 | 4.8 | GO:0035877 | death effector domain binding(GO:0035877) |
1.6 | 8.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.6 | 8.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.6 | 4.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.6 | 3.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.6 | 6.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.6 | 17.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.6 | 3.1 | GO:0034618 | arginine binding(GO:0034618) |
1.6 | 7.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.6 | 3.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.5 | 13.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.5 | 4.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.5 | 1.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.5 | 7.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.5 | 4.6 | GO:0070840 | dynein complex binding(GO:0070840) |
1.5 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 19.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.5 | 4.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.5 | 19.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.4 | 5.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.4 | 4.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.4 | 5.8 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.4 | 5.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.4 | 4.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.4 | 5.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.4 | 4.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.4 | 4.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.4 | 4.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.4 | 30.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.4 | 10.8 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.3 | 2.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 9.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.3 | 34.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.3 | 4.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.3 | 10.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.3 | 6.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.3 | 6.6 | GO:0035473 | lipase binding(GO:0035473) |
1.3 | 9.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.3 | 10.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.3 | 9.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 5.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.3 | 3.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.3 | 9.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.3 | 3.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.3 | 5.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.3 | 6.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.3 | 7.6 | GO:0034046 | poly(G) binding(GO:0034046) |
1.3 | 5.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 11.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 10.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.3 | 5.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.3 | 16.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.3 | 3.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.2 | 5.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.2 | 5.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 3.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.2 | 3.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.2 | 2.4 | GO:0050693 | LBD domain binding(GO:0050693) |
1.2 | 20.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.2 | 10.9 | GO:0048185 | activin binding(GO:0048185) |
1.2 | 3.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 4.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.2 | 3.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.2 | 16.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.2 | 5.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 5.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.2 | 3.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.2 | 20.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.2 | 5.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.2 | 3.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 11.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.2 | 5.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.2 | 13.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 3.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.2 | 6.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.2 | 5.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.1 | 6.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.1 | 4.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.1 | 3.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.1 | 30.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.1 | 40.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.1 | 11.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.1 | 19.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.1 | 5.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.1 | 5.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 3.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.1 | 3.3 | GO:0097016 | L27 domain binding(GO:0097016) |
1.1 | 3.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 27.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.1 | 13.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 5.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 5.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.1 | 3.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 2.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.1 | 31.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 7.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.1 | 2.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.1 | 8.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 24.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.1 | 14.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.1 | 5.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.1 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.1 | 7.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.1 | 3.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.1 | 2.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.1 | 4.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 12.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.1 | 17.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.1 | 3.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 12.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 18.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.0 | 2.1 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 29.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.0 | 5.2 | GO:0000182 | rDNA binding(GO:0000182) |
1.0 | 36.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.0 | 12.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.0 | 29.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.0 | 5.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.0 | 3.0 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 79.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
1.0 | 4.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 66.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 5.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.0 | 7.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 3.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.0 | 3.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 1.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.0 | 11.0 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.0 | 4.0 | GO:0030984 | kininogen binding(GO:0030984) |
1.0 | 7.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.0 | 3.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 5.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.0 | 4.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 2.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 10.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 4.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 2.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.0 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.0 | 4.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.0 | 1.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.0 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.0 | 5.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.0 | 4.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.0 | 6.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 14.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 11.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 16.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.9 | 5.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.9 | 1.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 8.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.9 | 3.8 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 5.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.9 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 3.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 4.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 8.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.9 | 2.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.9 | 1.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 5.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 7.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.9 | 1.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.9 | 3.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.9 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.9 | 8.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.9 | 5.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.9 | 2.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.9 | 3.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 4.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.9 | 2.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.9 | 3.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 4.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 4.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 1.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 14.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.9 | 2.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 9.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.9 | 3.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.9 | 8.5 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 2.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 17.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.8 | 2.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.8 | 1.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.8 | 0.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.8 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 2.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 16.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 2.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 2.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.8 | 1.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.8 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 4.1 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 4.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 2.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 2.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 3.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 1.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 10.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 3.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.8 | 1.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 3.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 13.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.8 | 4.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.8 | 4.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 14.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 1.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 19.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.8 | 6.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.8 | 2.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.8 | 9.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 3.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.8 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 6.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 10.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.8 | 3.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 4.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.8 | 16.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.8 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.8 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 7.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 3.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 3.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 3.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 3.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.8 | 1.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.8 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 2.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 9.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.8 | 21.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 12.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 3.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 1.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.7 | 3.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 5.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 2.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 2.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 6.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.7 | 10.9 | GO:0004601 | peroxidase activity(GO:0004601) |
0.7 | 2.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.7 | 2.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 15.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 3.6 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.7 | 2.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 2.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 14.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.7 | 7.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.7 | 94.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.7 | 4.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.7 | 14.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 2.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 2.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 3.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 1.4 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.7 | 10.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 1.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.7 | 4.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 9.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 4.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.7 | 2.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 2.1 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 1.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 5.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 4.0 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.7 | 2.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 3.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 2.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 62.5 | GO:0070736 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.7 | 4.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 1.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.7 | 3.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 2.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 3.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.6 | 4.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 3.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 5.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 1.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 1.3 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 9.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.6 | 4.5 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 33.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 5.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 9.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 3.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 4.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 3.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 12.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.6 | 1.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 8.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.6 | 0.6 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.6 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 2.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 1.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.6 | 11.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 1.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.6 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 6.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 1.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 4.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 0.6 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.6 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 3.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 4.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 1.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 6.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.6 | 12.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 2.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.6 | 6.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.6 | 4.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 3.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 3.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.8 | GO:0018590 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.6 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 28.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 2.3 | GO:0015288 | porin activity(GO:0015288) |
0.6 | 4.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 2.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 2.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 2.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.6 | 1.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 6.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.6 | 1.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 7.3 | GO:0034781 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.6 | 100.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.6 | 12.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 11.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 3.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 2.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 6.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 2.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 9.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 1.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 2.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 4.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 9.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 2.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 36.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 2.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 2.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 1.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 3.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 2.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 1.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.5 | 16.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 1.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.5 | 1.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 23.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 8.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.5 | 1.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 8.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 0.5 | GO:0097617 | annealing activity(GO:0097617) |
0.5 | 1.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 4.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.5 | 8.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 1.5 | GO:0050661 | NADP binding(GO:0050661) |
0.5 | 4.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.5 | 2.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 7.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.5 | 4.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 10.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 5.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 3.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 10.1 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 3.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 4.5 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 21.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 3.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 4.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 5.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 9.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 5.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 8.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 1.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 3.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 6.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 2.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 2.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 22.6 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 3.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.5 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.5 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 4.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 4.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 2.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 2.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 7.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 1.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 1.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 4.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 4.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 1.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 3.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 13.1 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 3.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 7.4 | GO:0045502 | dynein binding(GO:0045502) |
0.5 | 2.8 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 4.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 2.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 14.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 3.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 3.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 4.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.4 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 0.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 1.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 0.9 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.4 | 16.0 | GO:0051287 | NAD binding(GO:0051287) |
0.4 | 6.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 30.5 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 0.9 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 3.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 3.8 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 5.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 9.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 5.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 5.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 2.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 1.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 1.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 2.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 1.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.4 | 6.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 1.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.4 | 4.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 3.6 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 4.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 8.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 1.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 6.3 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 15.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 9.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 3.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 4.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 2.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 0.8 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.4 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 2.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 3.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 10.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.4 | 1.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 0.7 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 3.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 4.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.4 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 4.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 2.6 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.4 | 6.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 8.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.4 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 3.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 1.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 11.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 14.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 1.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 6.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.4 | 1.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 1.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 1.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 2.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 2.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 2.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 6.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 62.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 9.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 4.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 2.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 3.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.3 | 10.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 2.3 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 3.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 1.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 13.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 1.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 10.7 | GO:0060090 | binding, bridging(GO:0060090) |
0.3 | 1.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 1.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.3 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 6.1 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 2.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 0.3 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.3 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 9.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.3 | 3.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 0.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.3 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 1.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 2.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 5.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 0.9 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 8.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.6 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) D-lysine oxidase activity(GO:0043912) |
0.3 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 19.6 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.4 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 10.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 8.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 5.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 2.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 2.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.3 | 2.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 18.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 3.4 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.3 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 0.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 1.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 2.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 21.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 2.5 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.3 | 8.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 5.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 141.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 1.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.3 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.3 | GO:0032405 | mismatch repair complex binding(GO:0032404) MutLalpha complex binding(GO:0032405) |
0.3 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 3.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 5.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 1.3 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 3.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.0 | GO:0090484 | drug transporter activity(GO:0090484) |
0.2 | 12.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 40.4 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 1.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 7.7 | GO:0016853 | isomerase activity(GO:0016853) |
0.2 | 5.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.2 | 1.6 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 14.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 12.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 2.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 6.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 24.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.5 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 7.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 11.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 2.2 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
0.2 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.2 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.2 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.4 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 8.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 8.7 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 19.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 5.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 3.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 3.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 14.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 1.6 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.2 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 3.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 9.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 1.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 5.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 9.6 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 5.9 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 3.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 8.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 6.6 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 2.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 14.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 5.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 2.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.6 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 1.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 1.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 3.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 20.7 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 6.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 8.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 5.1 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 1.2 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.0 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 3.5 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 3.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.5 | 2.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
2.3 | 42.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.2 | 17.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.1 | 27.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.1 | 43.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.0 | 67.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.9 | 44.7 | PID EPO PATHWAY | EPO signaling pathway |
1.9 | 9.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.8 | 29.6 | PID IGF1 PATHWAY | IGF1 pathway |
1.7 | 22.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.7 | 3.5 | ST STAT3 PATHWAY | STAT3 Pathway |
1.7 | 8.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.6 | 13.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.6 | 26.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.6 | 20.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.6 | 63.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.5 | 10.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.5 | 66.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.5 | 16.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.5 | 9.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 14.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.4 | 12.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.4 | 48.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.4 | 8.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 8.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.4 | 17.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.4 | 28.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.4 | 21.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.3 | 15.9 | ST GAQ PATHWAY | G alpha q Pathway |
1.3 | 35.6 | PID RHOA PATHWAY | RhoA signaling pathway |
1.3 | 5.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.3 | 21.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.3 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.3 | 31.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.3 | 23.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.2 | 45.3 | PID P53 REGULATION PATHWAY | p53 pathway |
1.2 | 15.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 21.4 | PID MYC PATHWAY | C-MYC pathway |
1.2 | 7.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.2 | 12.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.2 | 7.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.2 | 2.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.1 | 23.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.1 | 5.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.1 | 55.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.1 | 21.1 | PID RAS PATHWAY | Regulation of Ras family activation |
1.1 | 7.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.1 | 4.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.1 | 5.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.1 | 6.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.1 | 19.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.1 | 32.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 23.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.1 | 12.8 | PID BCR 5PATHWAY | BCR signaling pathway |
1.1 | 49.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.0 | 13.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.0 | 29.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.0 | 6.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.0 | 17.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.0 | 13.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.0 | 14.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.0 | 2.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.0 | 12.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 2.9 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 2.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 30.3 | PID P73PATHWAY | p73 transcription factor network |
0.9 | 5.4 | PID FOXO PATHWAY | FoxO family signaling |
0.9 | 21.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.9 | 1.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 2.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.9 | 1.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.9 | 21.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.9 | 15.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 9.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 9.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.8 | 2.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 5.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 2.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 10.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.8 | 15.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 4.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.8 | 24.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 2.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 5.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 8.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 17.7 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 9.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 14.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.7 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 4.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 8.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.7 | 7.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 15.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 9.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 5.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 4.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.6 | 7.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 3.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 5.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 6.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 13.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 9.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 5.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 5.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 6.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 6.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 7.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 18.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 6.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 3.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 10.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 2.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 6.4 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 8.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 8.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 8.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 2.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 5.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 4.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 6.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 5.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 7.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 7.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 2.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.3 | 7.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 5.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 1.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 2.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 10.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 2.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 17.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.6 | 3.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
3.2 | 3.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.6 | 2.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.5 | 37.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.3 | 39.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.2 | 8.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.2 | 17.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.1 | 25.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.0 | 14.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.0 | 21.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.0 | 31.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.9 | 31.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.9 | 34.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.9 | 22.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.8 | 23.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.8 | 10.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.8 | 12.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.8 | 46.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.7 | 13.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 20.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.6 | 24.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.6 | 26.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.5 | 36.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.5 | 20.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.5 | 35.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.5 | 29.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.5 | 4.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.4 | 8.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.4 | 21.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.4 | 8.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.3 | 40.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.3 | 18.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 13.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 11.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.3 | 12.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 22.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.3 | 12.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.2 | 1.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.2 | 8.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.2 | 24.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.2 | 109.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.1 | 9.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 16.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 19.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.1 | 6.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.1 | 21.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.1 | 32.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.1 | 10.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 22.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 23.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.0 | 8.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 15.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.0 | 3.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 1.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.0 | 6.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 5.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.0 | 5.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 24.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.0 | 14.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.0 | 5.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.0 | 7.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.0 | 23.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.0 | 7.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.0 | 10.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.0 | 1.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 16.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.0 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 1.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.9 | 1.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.9 | 4.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.9 | 27.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 2.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 11.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.9 | 9.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 57.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.9 | 34.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 5.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.9 | 4.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.8 | 19.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.8 | 4.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.8 | 25.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.8 | 1.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.8 | 77.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.8 | 6.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 7.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.8 | 6.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.8 | 7.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 16.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 8.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.8 | 15.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.8 | 8.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.8 | 6.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 8.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 3.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 6.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 5.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 22.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.7 | 6.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.7 | 5.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.7 | 7.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.7 | 2.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.7 | 18.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 4.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 6.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 13.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 25.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.6 | 14.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 26.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 10.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 14.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 10.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 5.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 15.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 8.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.6 | 7.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.6 | 20.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 7.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 5.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 7.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.6 | 13.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 8.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 9.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 8.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 5.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 11.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 13.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 3.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 12.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 3.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 7.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 2.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.5 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 7.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.5 | 7.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 10.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 81.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 7.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 3.2 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.5 | 2.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 14.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 9.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 5.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.5 | 30.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 7.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 5.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 8.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 3.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 5.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 21.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 1.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.5 | 4.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 8.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 5.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 1.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 6.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 2.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.5 | 5.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 2.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 6.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 2.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 6.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 30.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 3.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 1.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.4 | 28.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.4 | 1.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.4 | 8.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 2.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 5.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.4 | 4.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.4 | 3.1 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 11.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.4 | 5.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 1.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.4 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 5.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.3 | 9.5 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.3 | 1.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 8.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 3.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 5.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 4.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 6.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 2.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 1.8 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.3 | 25.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 1.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 10.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 3.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 4.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 2.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 21.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 0.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 3.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 5.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 2.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |